ESSA Pharma to Present at Upcoming March Investor Conferences

<br /> ESSA Pharma to Present at Upcoming March Investor Conferences<br />

PR Newswire


HOUSTON, Texas

and VANCOUVER, Canada,

Feb. 25, 2021

/PRNewswire/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that Dr. David R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will be presenting and hosting one-on-one meetings with investors at three upcoming virtual investor conferences.

Peter Virsik

, ESSA’s Chief Operating Officer, and

David S. Wood

, ESSA’s Chief Financial Officer, will also be available for one-on-one meetings.


Presentation Details

:


Event:

Cowen 41st Annual Health Care Conference


Date:

Thursday, March 4, 2021


Time

:

12:10 p.m. ET


Event:

H.C. Wainwright Annual Global Life Sciences Conference


Date:

Tuesday, March 9, 2021


Time (on-demand):

7:00 a.m. ET


Event

: Oppenheimer 31st Annual Healthcare Conference


Date:

Thursday, March 18, 2021


Time:

11:20 a.m. ET

Webcasts of the events can be accessed in the Investors/Events & Presentations section of ESSA’s website at

www.essapharma.com

. Following the events, the webcasts will be archived on the ESSA website for 90 days.


About ESSA Pharma Inc.


ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit

www.essapharma.com

and follow us on Twitter under

@ESSAPharma

.

Cision
View original content:

http://www.prnewswire.com/news-releases/essa-pharma-to-present-at-upcoming-march-investor-conferences-301235830.html

SOURCE ESSA Pharma Inc

If You Liked This Article Click To Share

Biotech